Anthony J Damore, MD
Obstetrics/Gynecology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 30
- 7 carriers
- Office
- 1
Offices
1 location · Center for Cardiovascular Care A Medical Corporation · 11 clinicians in this group
Hospitals listed: Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
30 plans · 7 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Damore’s office at (408) 993-9511 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
30 of 30 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G12987 · Current
Licensed to practise in California · since 1967 · expires 2027-06-30 · Temple University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$21,119
Medicare paid this office $21,119 for 149 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 126 | $13,456 | $75 |
| Telephone medical discussion with physician, 11-20 minutes | 35 | $3,855 | $79 |
| Complete ultrasound scan of pelvis | 19 | $2,116 | $101 |
Who their Medicare patients are
149 Original Medicare patients in 2024. Average age 76 · Women 100% · Also on Medicaid 7% · Health risk score 0.76. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 59% · Coronary heart disease 23% · Diabetes 17% · Cancer 15% · Depression 14% · Chronic kidney disease 12% · Atrial fibrillation 9%.
The office billed $35,840, Medicare allowed $30,182 and paid $21,119; for 273 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 149 | 273 | 76 | 0.76 | $35,840 | $21,119 |
| 2023 | 146 | 269 | 75 | 0.68 | $33,369 | $20,764 |
| 2022 | 178 | 367 | 75 | 0.83 | $46,105 | $27,489 |
| 2021 | 167 | 370 | 75 | 0.84 | $45,576 | $27,885 |
| 2020 | 181 | 388 | 75 | 0.93 | $45,993 | $22,653 |
| 2019 | 221 | 399 | 74 | 0.82 | $47,169 | $23,066 |
| 2018 | 220 | 373 | 74 | 0.85 | $45,982 | $19,781 |
| 2017 | 191 | 310 | 74 | 0.81 | $37,629 | $17,810 |
| 2016 | 201 | 348 | 74 | 0.83 | $58,827 | $28,777 |
| 2015 | 230 | 382 | 73 | 0.84 | $68,113 | $34,052 |
| 2014 | 178 | 304 | 74 | 0.82 | $53,271 | $25,606 |
| 2013 | 227 | 403 | 73 | 0.80 | $71,354 | $33,884 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Short return visit (20+ min) | 123 | $12,711 | $77 |
| Telephone medical discussion with physician, 11-20 minutes | 41 | $4,727 | $77 |
| Complete ultrasound scan of pelvis | 11 | $1,254 | $104 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 17 | $812 | $48 |
2022: 4 services
| Short return visit (20+ min) | 116 | $13,789 | $76 |
| Telephone medical discussion with physician, 11-20 minutes | 54 | $6,119 | $81 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 69 | $3,293 | $48 |
| Complete ultrasound scan of pelvis | 20 | $2,525 | $105 |
2021: 4 services
| Short return visit (20+ min) | 113 | $18,342 | $80 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 67 | $3,248 | $48 |
| Telephone medical discussion with physician, 11-20 minutes | 28 | $2,219 | $77 |
| Complete ultrasound scan of pelvis | 17 | $2,202 | $110 |
2020: 3 services
| Short return visit (20+ min) | 129 | $15,436 | $61 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 83 | $3,986 | $48 |
| Complete ultrasound scan of pelvis | 16 | $2,233 | $106 |
2019: 3 services
| Short return visit (20+ min) | 171 | $16,617 | $60 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 75 | $3,276 | $44 |
| Complete ultrasound scan of pelvis | 14 | $1,540 | $103 |
2018: 3 services
| Short return visit (20+ min) | 156 | $12,796 | $51 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 82 | $3,482 | $42 |
| Complete ultrasound scan of pelvis | 18 | $2,147 | $102 |
2017: 2 services
| Short return visit (20+ min) | 154 | $13,413 | $57 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 38 | $1,593 | $42 |
2016: 6 services
| Return visit (30+ min) | 91 | $10,290 | $87 |
| Short return visit (20+ min) | 72 | $6,307 | $63 |
| Long return visit (40+ min) | 56 | $5,954 | $106 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 13 | $1,684 | $130 |
| Complete ultrasound scan of pelvis | 11 | $1,257 | $105 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 15 | $782 | $52 |
2015: 6 services
| Return visit (30+ min) | 131 | $14,282 | $87 |
| Long return visit (40+ min) | 85 | $9,712 | $110 |
| Short return visit (20+ min) | 51 | $4,452 | $65 |
| Complete ultrasound scan of pelvis | 18 | $2,023 | $106 |
| New patient visit (45+ min) | 11 | $1,337 | $122 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 21 | $1,125 | $54 |
2014: 4 services
| Return visit (30+ min) | 134 | $12,890 | $79 |
| Long return visit (40+ min) | 35 | $4,410 | $126 |
| Short return visit (20+ min) | 38 | $4,255 | $58 |
| Complete ultrasound scan of pelvis | 13 | $1,808 | $121 |
2013: 5 services
| Return visit (30+ min) | 165 | $14,967 | $85 |
| Short return visit (20+ min) | 83 | $9,054 | $62 |
| Long return visit (40+ min) | 33 | $3,941 | $119 |
| Complete ultrasound scan of pelvis | 21 | $2,980 | $124 |
| New patient visit (45+ min) | 11 | $1,317 | $120 |
Drugs they prescribed that Part D paid
$63,877
Pharmacies billed $63,877 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
533 generic and 106 brand-name prescriptions · $63,877 in drug cost · 23 antibiotic prescriptions to 19 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 14 | $16,403 | $1,172 |
| Premarin | 11 | $5,424 | $493 |
| Estradiol | 144 | $5,367 | $37 |
| Estradiol-Norethindrone Acetat | 51 | $4,735 | $93 |
| Yuvafem | 14 | $2,188 | $156 |
See all 18 drugs
| Myrbetriq | 14 | $16,403 | $1,172 |
| Premarin | 11 | $5,424 | $493 |
| Estradiol | 144 | $5,367 | $37 |
| Estradiol-Norethindrone Acetat | 51 | $4,735 | $93 |
| Yuvafem | 14 | $2,188 | $156 |
| Estradiol (Twice Weekly) | 20 | $1,997 | $100 |
| Estrogel | 13 | $1,988 | $153 |
| Estradiol (Once Weekly) | 17 | $1,587 | $93 |
| Betamethasone Valerate | 38 | $1,169 | $31 |
| Clotrimazole-Betamethasone | 26 | $900 | $35 |
| Valacyclovir | 11 | $549 | $50 |
| Clobetasol Propionate | 20 | $483 | $24 |
| Alendronate | 22 | $337 | $15 |
| Ibandronate | 12 | $330 | $28 |
| Nitrofurantoin Mono-Macro | 17 | $264 | $16 |
| Lorazepam | 31 | $238 | $8 |
| Fluconazole | 19 | $145 | $8 |
| Ibuprofen | 13 | $102 | $8 |
Year by year
| 2024 | 639 | 136 | None | 17% | $63,877 |
| 2023 | 618 | 132 | None | 19% | $75,378 |
| 2022 | 685 | 142 | 0% (0) | 24% | $89,174 |
| 2021 | 654 | 136 | None | 22% | $89,272 |
| 2020 | 756 | 148 | None | 23% | $102,465 |
| 2019 | 693 | 155 | None | 26% | $75,974 |
| 2018 | 602 | 141 | None | None | $76,043 |
| 2017 | 608 | 129 | 0% (0) | 29% | $82,141 |
| 2016 | 606 | 121 | None | 30% | $69,253 |
| 2015 | 668 | 131 | None | 29% | $73,535 |
| 2014 | 644 | 142 | None | 27% | $66,783 |
| 2013 | 614 | 128 | None | 32% | $59,020 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 18 drugs
| Myrbetriq | 18 | $18,424 | $1,024 |
| Femring | 12 | $8,861 | $738 |
| Premarin | 14 | $6,935 | $495 |
| Estradiol | 122 | $6,566 | $54 |
| Estradiol-Norethindrone Acetat | 40 | $4,318 | $108 |
| Estradiol (Once Weekly) | 25 | $2,707 | $108 |
| Yuvafem | 11 | $1,941 | $176 |
| Estradiol (Twice Weekly) | 11 | $1,621 | $147 |
| Clobetasol Propionate | 18 | $988 | $55 |
| Clotrimazole-Betamethasone | 27 | $764 | $28 |
| Nitrofurantoin Mono-Macro | 23 | $505 | $22 |
| Betamethasone Valerate | 14 | $392 | $28 |
| Alendronate | 23 | $326 | $14 |
| Fluconazole | 24 | $251 | $10 |
| Zolpidem | 12 | $115 | $10 |
| Ibuprofen | 16 | $95 | $6 |
| Lorazepam | 20 | $89 | $4 |
| Sertraline | 12 | $74 | $6 |
2022: 21 drugs
| Myrbetriq | 19 | $21,589 | $1,136 |
| Premarin | 26 | $11,900 | $458 |
| Femring | 15 | $9,805 | $654 |
| Estradiol | 141 | $6,879 | $49 |
| Estradiol (Twice Weekly) | 26 | $4,033 | $155 |
| Bijuva | 12 | $3,085 | $257 |
| Risedronate Sodium Dr | 12 | $2,985 | $249 |
| Estradiol (Once Weekly) | 26 | $2,702 | $104 |
| Estradiol-Norethindrone Acetat | 26 | $2,677 | $103 |
| Valacyclovir | 18 | $1,572 | $87 |
| Clotrimazole-Betamethasone | 20 | $989 | $49 |
| Metronidazole | 16 | $889 | $56 |
| Oxybutynin Chloride Er | 16 | $866 | $54 |
| Clobetasol Propionate | 22 | $782 | $36 |
| Betamethasone Valerate | 22 | $693 | $32 |
| Nitrofurantoin Mono-Macro | 22 | $464 | $21 |
| Lorazepam | 47 | $390 | $8 |
| Fluconazole | 35 | $288 | $8 |
| Oxybutynin Chloride | 14 | $264 | $19 |
| Zolpidem | 11 | $100 | $9 |
| Ibuprofen | 15 | $73 | $5 |
2021: 20 drugs
| Myrbetriq | 28 | $24,352 | $870 |
| Femring | 18 | $10,690 | $594 |
| Premarin | 18 | $9,292 | $516 |
| Estradiol | 113 | $5,430 | $48 |
| Estradiol (Once Weekly) | 17 | $3,065 | $180 |
| Estradiol-Norethindrone Acetat | 17 | $2,585 | $152 |
| Combipatch | 12 | $2,555 | $213 |
| Estradiol (Twice Weekly) | 11 | $2,161 | $196 |
| Oxybutynin Chloride Er | 25 | $1,585 | $63 |
| Valacyclovir | 26 | $1,448 | $56 |
| Clobetasol Propionate | 32 | $1,311 | $41 |
| Clotrimazole-Betamethasone | 15 | $669 | $45 |
| Nitrofurantoin Mono-Macro | 21 | $603 | $29 |
| Lorazepam | 56 | $447 | $8 |
| Betamethasone Valerate | 14 | $394 | $28 |
| Oxybutynin Chloride | 15 | $262 | $17 |
| Fluconazole | 23 | $222 | $10 |
| Alendronate | 12 | $148 | $12 |
| Zolpidem | 16 | $105 | $7 |
| Fluoxetine | 11 | $101 | $9 |
2020: 21 drugs
| Myrbetriq | 23 | $19,607 | $852 |
| Premarin | 38 | $16,747 | $441 |
| Femring | 21 | $11,163 | $532 |
| Estradiol | 138 | $8,823 | $64 |
| Estradiol (Once Weekly) | 21 | $3,681 | $175 |
| Estradiol (Twice Weekly) | 22 | $3,459 | $157 |
| Estradiol-Norethindrone Acetat | 24 | $3,394 | $141 |
| Combipatch | 13 | $2,584 | $199 |
| Clobetasol Propionate | 27 | $2,489 | $92 |
| Yuvafem | 13 | $2,353 | $181 |
| Progesterone | 11 | $987 | $90 |
| Metronidazole | 11 | $848 | $77 |
| Oxybutynin Chloride | 32 | $599 | $19 |
| Norethindron-Ethinyl Estradiol | 12 | $570 | $47 |
| Oxybutynin Chloride Er | 14 | $527 | $38 |
| Nitrofurantoin Mono-Macro | 19 | $452 | $24 |
| Lorazepam | 56 | $393 | $7 |
| Clotrimazole-Betamethasone | 20 | $390 | $20 |
| Fluconazole | 28 | $199 | $7 |
| Fluoxetine | 15 | $193 | $13 |
| Zolpidem | 15 | $107 | $7 |
2019: 18 drugs
| Estradiol | 142 | $14,491 | $102 |
| Premarin | 22 | $9,934 | $452 |
| Femring | 18 | $8,656 | $481 |
| Myrbetriq | 11 | $5,108 | $464 |
| Combipatch | 12 | $2,238 | $187 |
| Metronidazole | 24 | $1,906 | $79 |
| Yuvafem | 15 | $1,848 | $123 |
| Betamethasone Valerate | 29 | $1,147 | $40 |
| Valacyclovir | 19 | $1,044 | $55 |
| Oxybutynin Chloride Er | 18 | $769 | $43 |
| Clotrimazole-Betamethasone | 27 | $746 | $28 |
| Lorazepam | 45 | $371 | $8 |
| Nitrofurantoin Mono-Macro | 21 | $335 | $16 |
| Oxybutynin Chloride | 13 | $334 | $26 |
| Venlafaxine Hcl Er | 15 | $251 | $17 |
| Alendronate | 12 | $198 | $17 |
| Fluconazole | 33 | $188 | $6 |
| Zolpidem | 16 | $174 | $11 |
2018: 19 drugs
| Premarin | 24 | $10,328 | $430 |
| Yuvafem | 29 | $6,796 | $234 |
| Estradiol | 64 | $6,629 | $104 |
| Estrace | 15 | $5,256 | $350 |
| Lopreeza | 11 | $3,376 | $307 |
| Oxybutynin Chloride Er | 37 | $2,281 | $62 |
| Combipatch | 12 | $2,004 | $167 |
| Valacyclovir | 15 | $1,106 | $74 |
| Venlafaxine | 13 | $817 | $63 |
| Betamethasone Valerate | 13 | $484 | $37 |
| Oxybutynin Chloride | 11 | $292 | $27 |
| Lorazepam | 36 | $281 | $8 |
| Clotrimazole-Betamethasone | 12 | $279 | $23 |
| Lidocaine | 13 | $224 | $17 |
| Alendronate | 19 | $211 | $11 |
| Fluconazole | 21 | $207 | $10 |
| Zolpidem | 23 | $173 | $8 |
| Venlafaxine Hcl Er | 12 | $83 | $7 |
| Ciprofloxacin | 15 | $75 | $5 |
2017: 17 drugs
| Estrace | 34 | $8,678 | $255 |
| Myrbetriq | 20 | $7,880 | $394 |
| Premarin | 25 | $7,491 | $300 |
| Yuvafem | 23 | $6,692 | $291 |
| Vesicare | 13 | $6,609 | $508 |
| Climara Pro | 17 | $5,525 | $325 |
| Lopreeza | 20 | $3,682 | $184 |
| Estradiol | 52 | $3,470 | $67 |
| Clobetasol Propionate | 17 | $2,740 | $161 |
| Combipatch | 13 | $2,035 | $157 |
| Valacyclovir | 30 | $1,637 | $55 |
| Mimvey | 11 | $1,558 | $142 |
| Oxybutynin Chloride Er | 21 | $948 | $45 |
| Clotrimazole-Betamethasone | 13 | $420 | $32 |
| Fluconazole | 21 | $400 | $19 |
| Lorazepam | 36 | $209 | $6 |
| Zolpidem | 22 | $135 | $6 |
2016: 21 drugs
| Premarin | 39 | $8,949 | $229 |
| Estrace | 37 | $8,244 | $223 |
| Vagifem | 27 | $7,330 | $271 |
| Femring | 11 | $3,992 | $363 |
| Clobetasol Propionate | 24 | $3,651 | $152 |
| Myrbetriq | 11 | $3,249 | $295 |
| Valacyclovir | 27 | $1,921 | $71 |
| Estradiol | 49 | $1,518 | $31 |
| Mimvey | 11 | $1,477 | $134 |
| Lopreeza | 15 | $1,387 | $92 |
| Tinidazole | 20 | $1,192 | $60 |
| Progesterone | 12 | $822 | $69 |
| Oxybutynin Chloride Er | 12 | $534 | $45 |
| Clotrimazole-Betamethasone | 13 | $470 | $36 |
| Betamethasone Valerate | 15 | $410 | $27 |
| Oxybutynin Chloride | 15 | $392 | $26 |
| Fluconazole | 25 | $324 | $13 |
| Lorazepam | 33 | $304 | $9 |
| Lidocaine | 12 | $149 | $12 |
| Ciprofloxacin | 15 | $110 | $7 |
| Zolpidem | 11 | $83 | $8 |
2015: 21 drugs
| Vesicare | 15 | $8,330 | $555 |
| Premarin | 43 | $7,716 | $179 |
| Estrace | 30 | $5,712 | $190 |
| Clobetasol Propionate | 23 | $4,697 | $204 |
| Myrbetriq | 14 | $4,086 | $292 |
| Vagifem | 21 | $3,789 | $180 |
| Estradiol-Norethindrone Acetat | 21 | $3,518 | $168 |
| Estradiol | 74 | $2,333 | $32 |
| Mimvey | 16 | $1,487 | $93 |
| Valacyclovir | 22 | $1,371 | $62 |
| Lopreeza | 11 | $1,219 | $111 |
| Progesterone | 16 | $917 | $57 |
| Lidocaine | 33 | $907 | $27 |
| Oxybutynin Chloride Er | 11 | $621 | $56 |
| Clotrimazole-Betamethasone | 12 | $535 | $45 |
| Oxybutynin Chloride | 25 | $520 | $21 |
| Betamethasone Valerate | 20 | $505 | $25 |
| Zolpidem | 12 | $360 | $30 |
| Paroxetine | 20 | $185 | $9 |
| Lorazepam | 22 | $170 | $8 |
| Fluconazole | 21 | $136 | $6 |
2014: 20 drugs
| Vesicare | 30 | $12,216 | $407 |
| Premarin | 41 | $8,666 | $211 |
| Estradiol-Norethindrone Acetat | 40 | $5,296 | $132 |
| Vagifem | 23 | $4,222 | $184 |
| Estrace | 22 | $3,574 | $162 |
| Mimvey | 25 | $3,295 | $132 |
| Vivelle-Dot | 12 | $2,080 | $173 |
| Clobetasol Propionate | 21 | $1,615 | $77 |
| Estradiol | 31 | $1,011 | $33 |
| Lidocaine | 34 | $1,002 | $29 |
| Metronidazole | 22 | $610 | $28 |
| Valacyclovir | 12 | $527 | $44 |
| Oxybutynin Chloride | 18 | $479 | $27 |
| Betamethasone Valerate | 19 | $466 | $25 |
| Alendronate | 16 | $273 | $17 |
| Fluconazole | 16 | $247 | $15 |
| Fluoxetine | 12 | $170 | $14 |
| Lorazepam | 27 | $169 | $6 |
| Zolpidem | 18 | $145 | $8 |
| Ciprofloxacin | 20 | $92 | $5 |
2013: 18 drugs
| Vesicare | 46 | $14,494 | $315 |
| Premarin | 57 | $9,546 | $167 |
| Estradiol-Norethindrone Acetat | 40 | $4,250 | $106 |
| Estrace | 18 | $2,868 | $159 |
| Vagifem | 22 | $2,759 | $125 |
| Vivelle-Dot | 14 | $2,718 | $194 |
| Mimvey | 20 | $1,686 | $84 |
| Prefest | 12 | $1,100 | $92 |
| Estradiol | 39 | $963 | $25 |
| Betamethasone Valerate | 23 | $614 | $27 |
| Alendronate | 23 | $400 | $17 |
| Lidocaine | 22 | $399 | $18 |
| Clobetasol Propionate | 15 | $324 | $22 |
| Fluoxetine | 15 | $281 | $19 |
| Lorazepam | 23 | $190 | $8 |
| Oxybutynin Chloride | 12 | $167 | $14 |
| Fluconazole | 16 | $153 | $10 |
| Zolpidem | 22 | $122 | $6 |
Money from drug and device companies
$130 in 2025
| 2025 | 4 | 10 | None | $130 |
| 2024 | 4 | 18 | None | $378 |
| 2023 | 5 | 24 | None | $335 |
| 2022 | 5 | 17 | None | $234 |
| 2021 | 3 | 22 | None | $244 |
| 2020 | 2 | 4 | None | $70 |
| 2019 | 5 | 12 | None | $252 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Mayne Pharma Commercial | None | $41 | 5 payments
|
| Astellas Pharma US | Veozah | $37 | 2 payments
|
| Sumitomo Pharma America | Myfembree | $35 | 2 payments
|
| Exact Sciences | Cologuard Collection Kit | $17 | 1 payment
|
See all 10 published payments
| Sumitomo Pharma America | Meals · 2025-12-04 | Gemtesa | $14 |
| Astellas Pharma US | Meals · 2025-07-18 | Veozah | $17 |
| Mayne Pharma Commercial | Meals · 2025-06-19 | None | $12 |
| Mayne Pharma Commercial | Meals · 2025-06-19 | None | $2 |
| Mayne Pharma Commercial | Meals · 2025-05-20 | None | $10 |
| Mayne Pharma Commercial | Meals · 2025-04-10 | None | $10 |
| Exact Sciences | Meals · 2025-03-21 | Cologuard Collection Kit | $17 |
| Mayne Pharma Commercial | Meals · 2025-03-14 | None | $6 |
| Astellas Pharma US | Meals · 2025-03-13 | Veozah | $21 |
| Sumitomo Pharma America | Meals · 2025-02-20 | Myfembree | $21 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $378
| Mayne Pharma Commercial | Nextstellis | $258 | 13 payments
|
| Astellas Pharma US | Veozah | $52 | 2 payments
|
| Ascend Therapeutics US | Estrogel | $48 | 2 payments
|
| Exact Sciences | Cologuard Collection Kit | $20 | 1 payment
|
2023: $335
| Mayne Pharma Commercial | Nextstellis | $212 | 19 payments
|
| Ascend Therapeutics US | Estrogel | $52 | 2 payments
|
| Pfizer | Myfembree | $26 | 1 payment
|
| Astellas Pharma US | Myrbetriq | $23 | 1 payment
|
| Sumitomo Pharma America | Myfembree | $22 | 1 payment
|
2022: $234
| TherapeuticsMD | Annovera | $125 | 12 payments
|
| ASCEND Therapeutics US | Estrogel | $41 | 2 payments
|
| Abbvie | Lo Loestrin Fe | $32 | 1 payment
|
| Pfizer | Myfembree | $21 | 1 payment
|
| Avion Pharmaceuticals | Divigel | $15 | 1 payment
|
2021: $244
| TherapeuticsMD | Annovera | $170 | 18 payments
|
| Myovant Sciences | Myfembree | $39 | 2 payments
|
| Pfizer | Myfembree | $35 | 2 payments
|
2020: $70
| TherapeuticsMD | Annovera | $46 | 2 payments
|
| Ascend Therapeutics US | Binosto | $23 | 2 payments
|
2019: $252
| Pfizer | Premarin | $129 | 6 payments
|
| TherapeuticsMD | Imvexxy | $62 | 3 payments
|
| Becton Dickinson and | Bd Surepath | $24 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kyleena | $22 | 1 payment
|
| AMAG Pharmaceuticals | Intrarosa | $14 | 1 payment
|
Professional record
- NPI
- 1932131307
- Licence
- CA G12987California G12987: Current · expires 2027-06-30
- Trained
- Temple University School of Medicine, 1961
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 360 Dardanelli Ln, Suite 2a, Los Gatos, CA, 95032
- NPI first listed
- 2006-07-07
- NPI last updated
- 2015-07-28
This is when the NPI record was last certified, not a medical board exam.